What's Going On With Intuitive Surgical Stock Wednesday?

Benzinga
01/15

Intuitive Surgical, Inc. (NASDAQ:ISRG) stock fell Wednesday after the company posted preliminary fourth-quarter and full-year 2025 results.

The company reported expanded procedures, higher system placements and revenue gains in the fourth quarter and full year 2025.

According to Benzinga Pro, ISRG stock has gained over 4% in the past 6 months. Investors can gain exposure to the stock via iShares U.S. Medical Devices ETF (NYSE:IHI).

Procedure Expansion

Worldwide procedures using da Vinci and Ion systems grew about 18% in the fourth quarter versus last year.

Da Vinci procedures rose about 17% while Ion procedures jumped about 44%, the company said.

In 2025 overall, combined procedures increased approximately 19% compared with 2024.

Intuitive expects global da Vinci procedures to grow roughly 13% to 15% in 2026.

System Placements

The company placed 532 da Vinci surgical systems in the fourth quarter, including 303 da Vinci 5 units.

In 2025, Intuitive placed 1,721 da Vinci systems, the report said.

The earlier part of the year saw fewer Ion endoluminal system placements than in 2024.

Revenue Performance

Preliminary fourth quarter 2025 revenue was about $2.87 billion (Street view: $2.72 billion), up roughly 19% from the same quarter in 2024.

For the full year, the company tallied about $10.06 billion in revenue, an increase of roughly 21% from 2024.

Revenue gains were driven by higher procedure volumes and increased system placements.

Preliminary instruments and accessories revenue grew around 17% in the fourth quarter.

Full year instruments and accessories revenue rose about 19% compared with the prior year.

Preliminary systems revenue also climbed due to stronger placements and higher average selling prices.

CEO Dave Rosa said the company saw wider platform adoption and growing procedure volumes.

He added that the company remains focused on its goals to improve patient care and outcomes.

ISRG Price Action: Intuitive Surgical shares were down 4.24% at $538.01 at the time of publication on Wednesday, according to Benzinga Pro data.

Image via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10